Introduction
Interstitial lung disease (ILD) is a broad category of lung disorders that result in inflammation and fibrosis of the lung parenchyma. The pathogenesis of ILD is often associated with immune dysregulation, oxidative stress, and chronic inflammation.[1][2]
Traditional treatment approaches, such as corticosteroids and immunosuppressive drugs, provide symptomatic relief but often fail to halt disease progression.[3] As a result, there has been growing interest in complementary and integrative therapies, including yoga, Ayurvedic practices, and Yagya therapy, to improve quality of life and enhance overall respiratory function.[4][5]
Yagya therapy, derived from Vedic traditions, involves fire rituals accompanied by the chanting of mantras. The therapeutic effects of Yagya have been explored in various health conditions, including respiratory diseases. This review aims to evaluate the scientific evidence supporting the role of Yagya therapy as a supportive intervention in ILD management.
Mechanisms of Yagya Therapy
Yagya therapy is a multifaceted intervention that combines sound therapy, spiritual practices, and bioenergetic effects. The chanting of Vedic mantras during the fire ritual is believed to influence the body's biofield, promote mental clarity, and reduce stress.[6][7]
In addition, the presence of fire and specific offerings during the ritual are thought to generate positive ions and purify the environment, which may have beneficial effects on respiratory function and immune modulation.[8]
Research has shown that the vibrations produced during Yagya rituals may have a measurable impact on the human body’s electromagnetic field.[9] These vibrations are believed to affect the respiratory system by improving lung function, reducing oxidative stress, and enhancing immune responses.[10]
The biochemical effects of sound and vibration on cellular repair mechanisms have been studied, suggesting a potential role in reducing inflammation and promoting tissue healing in ILD patients.[11]
Impact of Yagya Therapy on Respiratory Health
Several studies have examined the effects of Yagya therapy on individuals with respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). Bera et al. demonstrated that the practice of Vedic chanting, a key component of Yagya therapy, led to improvements in lung function and reduction in symptoms of chronic respiratory diseases.[12] Furthermore, sound therapy, which is integral to the Yagya ritual, has been shown to have a positive effect on the immune system, potentially reducing inflammation and promoting airway relaxation.[13]
Research on effects of Yagya therapy in management of ILD is limited but promising. A study by Sharma et al. observed that patients who participated in regular Yagya rituals reported significant improvements in their symptoms, including reduced shortness of breath, improved exercise tolerance, and enhanced overall well-being.[14] These effects were attributed to reduction of stress and anxiety, which are known to exacerbate respiratory symptoms in ILD patients.[15]
The role of Yagya therapy in managing inflammation has also been supported by several studies. Yagya rituals, through the chanting of mantras, are believed to regulate the body's inflammatory response by modulating the autonomic nervous system and the endocrine system.[16] This regulation may help reduce chronic inflammation, a key factor in the pathophysiology of ILD.[2]
Yagya Therapy and Immune Modulation
In addition to its effects on inflammation, Yagya therapy has been shown to influence immune function. The fire and chanting rituals are thought to stimulate the production of endogenous antioxidants and cytokines that promote immune homeostasis.[17] This immunomodulatory effect may be particularly beneficial for ILD patients, as immune dysregulation plays a central role in disease progression. Yagya therapy may also promote an improved balance of pro-inflammatory and anti-inflammatory cytokines. A study by Agarwal et al. found that participation in Yagya rituals was associated with a decrease in levels of pro-inflammatory cytokines such as TNF-α and IL-6, and an increase in anti-inflammatory cytokines like IL-10.[18]
©